Evidence map›Paper›PMID 30763236›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2019

Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Girish S Kulkarni, Peter C Black, Srikala S Sridhar, Anil Kapoor, Alexandre R Zlotta, Bobby Shayegan, Ricardo A Rendon, Peter Chung, Theodorus van der Kwast, Nimira Alimohamed and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05503563 unknown statusnot on this mapstarted 2022, after this paper: background citation

A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder

TypeobservationalSponsorAssiut UniversityRan2022 to 2024Enrolled50ConditionsBladder CancerArmsterta modal bladder preservation
NCT07043790 nacompletednot on this mapstarted 2021, after this paper: background citation

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

TypeinterventionalSponsorAin Shams UniversityRan2021 to 2025Enrolled73ConditionsTransitional Cell Bladder Cancer, Cystectomy, RadiationArmsRadical cystectomy with pelvic lymphadenectomy, Trimodal therapy
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. A population-based analysis of patterns of care in patients with de novo muscle-invasive bladder cancer from Alberta, Canada.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  5. A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  6. Article
  7. Assessing the methodologic heterogeneity of Canadian Urological Association guidelines Adoption of the GRADE approach (2018-2023).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  8. Article
  9. Article
  10. Enhancing mHeliyon · 2024
    Article
  11. Article
  12. Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  13. Existing trends and applications of artificial intelligence in urothelial cancer A scoping review.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  14. Article
  15. Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  16. Radical cystectomy for clinical T4b urothelial carcinoma: An Ontario, single-center experience.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  17. Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  18. Article
  19. Cases - Clear-cell urothelial carcinoma of the bladder.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Girish S KulkarniDivision of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
Peter C BlackDepartment of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Srikala S SridharDivision of Hematology and Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
Anil KapoorSection of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Alexandre R ZlottaDivision of Urology, Departments of Surgery and Surgical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada.
Bobby ShayeganSection of Urology, Department of Surgery, McMaster University, Hamilton, ON, Canada.
Ricardo A RendonDepartment of Urology, Dalhousie University, Halifax, NS, Canada.
Peter ChungRadiation Medicine Program, Princess Margaret Cancer Center, University Health Network, Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Theodorus van der KwastLaboratory Medicine Program, University Hospital Network, Toronto, ON, Canada.
Nimira AlimohamedDivision of Medical Oncology, Department of Oncology, University of Calgary, Calgary, AB, Canada.
Yves FradetDivision of Urology, Department of Surgery, Laval University, Quebec City, QC, Canada.
Wassim KassoufDepartment of Urology, McGill University Health Center, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30763236
PMCPMC6737737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.